ArticleFrontiers in immunology2022

Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China.

Wendao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.